Emory University
Principal Investigator: Arshed A. Quyyumi, MD

The Texas Heart Institute
Co-Principal Investigators: Emerson C. Perin, MD, PhD; James T. Willerson, MD

Vanderbilt University School of Medicine
Douglas E. Vaughan, MD

AMR-001 is an autologous bone marrow derived CD 34 enriched cell product for the treatment of damaged heart muscle following Acute Myocardial Infarction (AMI).